- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-ELL2
ELL2 Polyclonal Antibody for WB, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IF, IP, ChIP, ELISA
Conjugaison
Non conjugué
N° de cat : 12727-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules HeLa, cellules HepG2, cellules L02, tissu cérébral de rat, tissu cérébral de souris, tissu d'estomac de souris |
| Résultats positifs en IP | tissu cérébral de souris |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 1 publications below |
| WB | See 6 publications below |
| IF | See 1 publications below |
| ChIP | See 1 publications below |
Informations sur le produit
12727-1-AP cible ELL2 dans les applications de WB, IF, IP, ChIP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Réactivité citée | Humain, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | ELL2 Protéine recombinante Ag3428 |
| Nom complet | elongation factor, RNA polymerase II, 2 |
| Masse moléculaire calculée | 640 aa, 72 kDa |
| Poids moléculaire observé | 72 kDa |
| Numéro d’acquisition GenBank | BC028412 |
| Symbole du gène | ELL2 |
| Identification du gène (NCBI) | 22936 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
ELL2 (Elongation Factor for RNA Polymerase II 2) is a key transcriptional elongation factor that regulates RNA polymerase II (Pol II) during mRNA synthesis (PMID: 34265249). It belongs to the ELL gene family, which includes ELL1, ELL2, and ELL3, and plays a crucial role in controlling the elongation phase of transcription (PMID: 9108030). ELL2 is an androgen-responsive gene that is expressed by prostate epithelial cells and is frequently down-regulated in prostate cancer (PMID: 29179998).
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for ELL2 antibody 12727-1-AP | Download protocol |
| IP protocol for ELL2 antibody 12727-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Cell MicroRNA Directly Enhances Mitochondrial Translation during Muscle Differentiation.
| ||
Mol Cell RNA Pol II preferentially regulates ribosomal protein expression by trapping disassociated subunits | ||
Cell Death Dis TRIB1 regulates liver regeneration by antagonizing the NRF2-mediated antioxidant response | ||
J Biol Chem Cytoplasmic poly(A)-binding protein 1 (PABPC1) interacts with the RNA-binding protein hnRNPLL and thereby regulates immunoglobulin secretion in plasma cells. | ||
FASEB J Androgen receptor splicing variant 7 (ARv7) promotes DNA damage response in prostate cancer cells |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
FH Beth (Verified Customer) (10-05-2017) | Using LI-COR imaging system.
![]() |



